Timber Pharmaceuticals Inc
TMBR
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.18M
Close$
Share Statistics
| Market cap | $1.18 Million |
|---|---|
| Enterprise Value | $-798,315.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.19 |
| Beta | -0.65 |
| Outstanding Shares | 3,078,297 |
Return
| Return on Equity | 574.09% |
|---|---|
| Return on Assets | -452.39% |
| Return on Invested Capital | 631.83% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | -0.34 |
| Enterprise Value to Revenue | -9.6 |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.68 |
| Debt to Equity | -0.21 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Timber Pharmaceuticals Inc
6 employeesTimber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-actio...